She works with products that she wishes she had had when in clinical practice, products that are important to have as a woman and those that she wants her daughter to have access to. She has spent the last 17 years in Clinical Affairs, Medical Affairs, Professional Education and Commercialization in the medical device environment and nearly 30 years total in women's health. Jennifer was instrumental in the Ayldia Health team the brought the Jada—a postpartum hemorrhage intervention—to market and now is the Vice President of Market Development for Raydient Oximetry. Raydient Oximetry is developing Lumerah™, a device that accurately detects fetal oxygenation during labor.